Kai Ming Medical -B (stock code: 2500) announced that the company has acquired the right to use the project land of the Hangzhou City Planning and Natural Resources Bureau in September 2021, which is located in the Hangzhou National High-Tech Industrial Development Zone, and is planned to be used for the development of the Ming Medical Life and Health Industry Park. On 17 November 2022, Kai Ming Medical and China Construction Group signed a construction contract with a total contract value of approximately RMB11.82 million, which is subject to disclosure due to the maximum applicable percentage exceeding 5%. The development project's underground construction is nearing completion, and the company expects the project to contribute to the Group's resource sharing and brand reach. Due...Show More

Kai Ming Medical -B (stock code: 2500) announced that the company has acquired the right to use the project land of the Hangzhou City Planning and Natural Resources Bureau in September 2021, which is located in the Hangzhou National High-Tech Industrial Development Zone, and is planned to be used for the development of the Ming Medical Life and Health Industry Park. On 17 November 2022, Kai Ming Medical and China Construction Group signed a construction contract with a total contract value of approximately RMB11.82 million, which is subject to disclosure due to the maximum applicable percentage exceeding 5%. The development project's underground construction is nearing completion, and the company expects the project to contribute to the Group's resource sharing and brand reach. Due to the failure to comply with the notices and notices provided for in Chapter 14 of the Listing Rules in a timely manner, the Company apologizes for this and has taken remedial measures, including the appointment of Dokine Corporate Advisory to conduct an internal control review. In addition, the trading of the company's shares will be suspended from 23 November 2023, pending the fulfilment of the re-licensing guidelines.